Dr. Muna S. Sunni

Dr. Bradley Miller completed his Pediatric residency (2000) and Pediatric Endocrinology fellowship (2003) at the Mayo Clinic. He is a Professor in Pediatric Endocrinology, and has been a member of the division since 2003. Dr. Miller has an interest in the role of the growth hormone (GH)/insulin-like growth factor (IGF) system in normal and abnormal growth in children. Additionally, he is interested in the growth and development of children following adversity including cancer and its therapies, fetal alcohol exposure, and international adoption. Dr. Miller is also interested in the endocrine aspects of abnormal glycosylation in children with Congenital Disorders of Glycosylation. Lastly, Dr. Miller is also interested in Achondroplasia and other skeletal dysplasia conditions. Dr. Miller is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Growth Hormone Deficiency (GHD), Pediatric Growth Hormone Deficiency, Hypopituitarism, Short Stature (Growth Disorders), and Hormone Replacement Therapy (HRT). Dr. Miller is board certified in American Board Of Pediatrics American Board Of Pediatrics - Pediatric Endocrinology.

Kyriakie Sarafoglou is a Pediatrics specialist and a Pediatric Endocrinologist practicing medicine in Minneapolis, Minnesota. Dr. Sarafoglou is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Congenital Adrenal Hyperplasia (CAH), Intersex, Familial Glucocorticoid Deficiency, Isolated ACTH Deficiency, and Hormone Replacement Therapy (HRT). Dr. Sarafoglou is board certified in Pediatric Endocrinology: American Board Of Pediatrics, 1997. Dr. Sarafoglou is currently accepting new patients.

I am a research clinician at International Diabetes Center (IDC). I work with patients participating in research studies related to type 1 and type 2 diabetes and new diabetes technology. For more information about the many studies offered through IDC, please call 952-993-3500. Being involved in diabetes research can help individuals better manage their diabetes or may help the next generation of people with diabetes. As Executive Director of the IDC, I also participate in training professionals in the US and internationally and publishing diabetes educational materials for patients and professionals. Translating new research findings into improvements in diabetes care is my major professional focus. We are finding that the best approach to improve care is by working as a team and to focus on the needs of each patient. My outreach diabetes clinic in Willmar Minnesota keeps me in clinical practice. My two granddaughters keep me active, amazed and inspired. Dr. Bergenstal is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Low Blood Sugar, Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), and Maturity Onset Diabetes of the Young. Dr. Bergenstal is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine-Endocrin,Diabetes&Metabolism. Dr. Bergenstal is currently accepting new patients.